Medscape Podcasts
Keeping Current
Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
Author
Medscape Podcasts
Category
Podcast website
Latest episode
Jun 30, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
A Patient With Type 2 Diabetes and Chronic Kidney Disease in Clinical Practice 16.06.2023 21:30
What do you do when your patient with type 2 diabetes (T2D) has a change in kidney function? Credit available for this activity expires: 6/15/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/993213?ecd=bdc_podcast_libsyn_mscpedu
Demystifying the Science of New Anti-Seizure Medications and Application to Clinical Practice 16.06.2023 29:56
Accept the challenge to be more ambitious for patients by learning how to navigate the complexity of anti-seizure medications. Credit available for this activity expires: 6/15/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991649?ecd=bdc_podcast_libsyn_mscpedu
Development of Heart Failure Following Myocardial Infarction: Why Risks Still Remain High 15.06.2023 20:08
Did you know that 1 in 5 patients develop heart failure within 5 years following myocardial infarction? Credit available for this activity expires: 6/15/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/993141?ecd=bdc_podcast_libsyn_mscpedu
Expert Exchange: Clinical Implications of the Latest Advances in Metastatic Breast Cancer 14.06.2023 34:33
Do you know how to personalize treatment for your patients with metastatic breast cancer (mBC)? How can you incorporate emerging treatment strategies? Credit available for this activity expires: 6/12/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/993007?ecd=bdc_podcast_libsyn_mscpedu
Meeting the Experts and Taking Action in Heart Failure 14.06.2023 22:33
Do you know the latest data and guidelines in patients with heart failure (HF)? Dr Zieroth reviews. Credit available for this activity expires: 6/13/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/992945?ecd=bdc_podcast_libsyn_mscpedu
Classification and Nomenclature of IC-MPGN and C3G: A Spectrum of Diseases or Distinct Entities? 09.06.2023 23:25
Discover expert tips from Dr Kavanagh on how to appropriately classify patients with C3G and IC-MPGN. Credit available for this activity expires: 6/7/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/992772?ecd=bdc_podcast_libsyn_mscpedu
Adherence to Lipid-Lowering Therapies: How Can We Tackle This Barrier Better? 06.06.2023 38:07
How can you help improve medication adherence? Drs Sabatine, Bosworth, and Tokgozoglu discuss. Credit available for this activity expires: 6/5/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991799?ecd=bdc_podcast_libsyn_mscpedu
Adherence to Lipid-Lowering Therapies: How Can We Tackle This Barrier Better? 06.06.2023 38:07
How can you help improve medication adherence? Drs Sabatine, Bosworth, and Tokgozoglu discuss. Credit available for this activity expires: 6/5/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991799?ecd=bdc_podcast_libsyn_mscpedu
A Patient Is Waiting for a Liver Transplant: What Can We Do Now and What Could We Have Done Better? 31.05.2023 27:20
Did you know that between 5% to 13% of patients with Wilson disease are liver transplanted? Credit available for this activity expires: 5/31/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/992473?ecd=bdc_podcast_libsyn_mscpedu
Reducing the Risks of Hyperkalemia in the Treatment of Heart Failure and Chronic Kidney Disease: What It Means for Management Teams 31.05.2023 42:38
Did you know that up to 47% of patients taking renin-angiotensin-aldosterone system inhibitors see their therapy discontinued after developing mild or moderate-to-severe hyperkalemia? Credit available for this activity expires: 5/31/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/992401?ecd=bdc_podcast_libsyn_mscpedu
Dengue Prevention: Integrating Vaccination Into Comprehensive Control Strategies Across Populations 22.05.2023 38:19
Do you know the priorities for implementing a successful dengue vaccination strategy? Credit available for this activity expires: 5/19/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991813?ecd=bdc_podcast_libsyn_mscpedu
Early-Stage Resectable Non-Small Cell Lung Cancer: Sharing Patient Perspectives 08.05.2023 35:18
The complexity of treatment has increased dramatically; how effectively are you communicating with your patients? Credit available for this activity expires: 05/04/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991508?ecd=bdc_podcast_libsyn_mscpedu
Gaining Control With Early Combination Lipid-Lowering Therapy: Applying Learnings From the Queen's Gambit 03.05.2023 36:29
Is initial combination lipid-lowering therapy really necessary? Expert faculty discuss. Credit available for this activity expires: 05/02/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991255?ecd=bdc_podcast_libsyn_mscpedu
Looking Forward to Thriving With HIV: Interventions to Improve and Maintain Health in People With HIV 01.05.2023 33:00
Did you know that kindness in the clinic can improve antiretroviral therapy adherence? Credit available for this activity expires: 4/28/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991298 ?ecd=bdc_podcast_libsyn_mscpedu
Three Cardiovascular Risk Cases: Why and Who Should We Be Testing for Lp(a) 18.04.2023 41:14
When to measure lipoprotein ( Lp ) (a) and what to do with it? Drs Ray and Kronenberg discuss. Credit available for this activity expires: 17/04/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990770?ecd=bdc_podcast_libsyn_mscpedu
Well Begun Is Half Done: Why and How Do We Assess Activity of the Complement Pathway in the Clinic? 14.04.2023 37:42
Do you want to gain expert insights on the role of kidney biopsy and complement assays for complement-mediated kidney diseases? Credit available for this activity expires: 4/13/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990635?ecd=bdc_podcast_libsyn_mscpedu
What's New in Diabetic Eye Disease Technologies 31.03.2023 35:08
Half of people with severe non-proliferative diabetic retinopathy will have proliferative disease within a year. What can be done? Credit available for this activity expires: 03/31/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989799?ecd=bdc_podcast_libsyn_mscpedu
Biosimilars in Multiple Sclerosis: Entering a New Era of Biologic Therapy 30.03.2023 37:54
Did you know what the inherent variability of all biologics and what degree of variation are acceptable by regulatory bodies ? Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989395?src=mkm_podcast_addon_989395
Are We Ready for Biosimilars in Multiple Sclerosis? Experts Discuss Lessons From Other Immune-Mediated Diseases 29.03.2023 34:40
What is the clinical use of biosimilars and how to best communicate with patients to avoid the nocebo effect? Credit available for this activity expires: 3/29/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990193?ecd=bdc_podcast_libsyn_mscpedu
Global Perspectives on Anti-Vascular Endothelial Growth Factor: If, When, and How to Switch 29.03.2023 1:01:13
Do you reload when switching? What intervals do you extend by? How long is feasible between treatments, and how do you monitor? Learn from the experts. Credit available for this activity expires: 28/03/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990120?ecd=bdc_podcast_libsyn_mscpedu
Clinical Trials in Focus: Durability of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies 28.03.2023 34:58
Do you know how study designs influence the data with anti - vascular endothelial growth factor (anti-VEGF) therapies ? Find out more. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[ArticleID]?src=mkm_podcast_addon_989801
Safeguarding the CKD Patient With or Without Diabetes in Primary Care: Quick Questions, Rapid Replies 27.03.2023 17:52
Did you know that SGLT2 blockade can reduce progression to ESKD by at least a decade in patients with mild-to-moderately decreased eGFR? Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990093?ecd=bdc_podcast_libsyn_mscpedu
Optimizing Treatments in Advanced Systemic Mastocytosis With Associated Hematological Neoplasm 27.03.2023 36:36
Do you know which you should be treating first -- the systemic mastocytosis (SM) or the associated hematological neoplasm (AHN)? Credit available for this activity expires: 3/24/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990024?ecd=bdc_podcast_libsyn_mscpedu
Diabetes Dialogue Part 2: Who Are Candidates for GLP-1 Receptor Agonist Therapy in Primary Care? 24.03.2023 18:54
Who should be taking a glucagon-like peptide-1 (GLP-1) receptor agonist (RA)? Join Drs Bain and Lin to find out. Credit available for this activity expires: 3/23/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989998?ecd=bdc_podcast_libsyn_mscpedu
Challenging the Harmful Myths About ASCVD Management: The Experts Set the Record Straight 23.03.2023 21:10
Do you know the latest information about dyslipidemia and atherosclerotic cardiovascular disease (ASCVD) risk? Drs Navar and Ray discuss. Credit available for this activity expires: 03/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[989864]?ecd=bdc_podcast_libsyn_mscpedu
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.